Left Ventricular Assist Device in Older Adults

Authors

Chris Caraang
Gregg M. Lanier, New York Medical CollegeFollow
Alan Gass, New York Medical CollegeFollow
Wilbert S. Aronow, New York Medical CollegeFollow
Chhaya A. Gupta

Journal Title

Heart Failure Clinics

First Page

619

Last Page

632

Document Type

Article

Publication Date

7-1-2017

Department

Medicine

Abstract

Left ventricular assist devices (LVADs) are an effective therapy for a growing and aging population in the background of limited donor supply. Selecting the proper patient involves assessment of indications, risk factors, scores for overall outcomes, assessment for right ventricular failure, and optimal timing of implantation. LVAD complications have a 5% to 10% perioperative mortality and complications of bleeding, thrombosis, stroke, infection, right ventricular failure, and device failure. As LVAD engineering technology evolves, so will the risk-prediction scores. Hence, more large-scale prospective data from multicenters will continually be required to aid in patient selection, reduce complications, and improve long-term outcomes.

Recommended Citation

Caraang, C., Lanier, G. M., Gass, A., Aronow, W. S., & Gupta, C. A. (2017). Left Ventricular Assist Device in Older Adults. Heart Failure Clinics, 13 (3), 619-632. https://doi.org/10.1016/j.hfc.2017.02.013

Publisher's Statement

Originally published in Heart Failure Clinics. The original material can be found here.